miércoles, 30 de octubre de 2019

Data falsification: still a problem in drug plants in India and China - STAT

Data falsification: still a problem in drug plants in India and China - STAT

Morning Rounds

Shraddha Chakradhar

What to read around the web today

  • Opinion: In generic drug plants in China and India, data falsification is still a problem. STAT
  • Missouri Health Director tracked menstrual periods of Planned Parenthood patients. NBC News
  • Taking stock of Alzheimer’s research: Experts offer takes on Biogen, the NIH, and the amyloid hypothesis. STAT Plus
  • Juul shipped at least a million contaminated pods, new lawsuit says. BuzzFeed News
  • Johnson & Johnson says recalled baby powder doesn’t have asbestos. The New York Times

No hay comentarios: